CTI BioPharma
CTIC
$9.09
Share price
0.00%
Change (1 day)
30.79%
Change (1 year)
Categories
Operating Margin for CTI BioPharma (CTIC)
Operating Margin as of April 2024 (TTM): -172.37%
According to CTI BioPharma 's latest financial reports and stock price the company's current Operating Margin is -172.37%. At the end of 2019 the company had an Operating Margin of -1,150.97%.
Operating Margin history for CTI BioPharma from 2001 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2019 | -1,150.97% | 995.63% |
| 2018 | -105.05% | -31.91% |
| 2017 | -154.28% | 76.69% |
| 2016 | -87.32% | -88.1% |
| 2015 | -733.86% | 381.56% |
| 2014 | -152.39% | 25.79% |
| 2013 | -121.15% | |
| 2010 | -23,434.17% | -78.65% |
| 2009 | -109,780.00% | 16146.65% |
| 2008 | -675.71% | -99.21% |
| 2007 | -85,173.23% | -30.48% |
| 2006 | -122,511.25% | 43755.83% |
| 2005 | -279.35% | -46.13% |
| 2004 | -518.53% | 4.75% |
| 2003 | -494.99% | -15.34% |
| 2002 | -584.68% | -56.33% |
| 2001 | -1,338.76% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 17.27% | -110.02% | 🇨🇭 Switzerland |
 Eli Lilly LLY | 24.66% | -114.31% | 🇺🇸 USA |
 Amgen AMGN | 34.59% | -120.07% | 🇺🇸 USA |
 Baxter BAX | -19.01% | -88.97% | 🇺🇸 USA |
 Incyte INCY | 15.90% | -109.22% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 19.24% | -111.16% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | -20.53% | -88.09% | 🇮🇱 Israel |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.